Institution: | (1) Department 114, Bristol-Myers Squibb Company, Pharmaceutical Research Institute, P.O. Box 5100, 06492 Wallingford, CT, USA;(2) Industrial Division, Bristol-Myers Squibb Company, Syracuse, NY, USA;(3) Frederick Cancer Research and Development Center, Frederick, MD, USA |